Evidence map›Paper›PMID 37426759›Full record

ArticleCell reports methods2023

hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data.

Samuel Morabito, Fairlie Reese, Negin Rahimzadeh, Emily Miyoshi, Vivek Swarup

Abstract read
In one paragraph

Article in Cell reports methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 595 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
595citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

595 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. iScience · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Targeting the CD4Molecular biomedicine · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Key regulatory elements of the TGFβ-LRRC15 axis predict disease progression and immunotherapy resistance across cancer types.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article

535 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samuel MorabitoMathematical, Computational, and Systems Biology (MCSB) Program, University of California, Irvine, Irvine, CA, USA.
Fairlie ReeseCenter for Complex Biological Systems (CCBS), University of California, Irvine, Irvine, CA, USA.
Negin RahimzadehMathematical, Computational, and Systems Biology (MCSB) Program, University of California, Irvine, Irvine, CA, USA.
Emily MiyoshiInstitute for Memory Impairments and Neurological Disorders (MIND), University of California, Irvine, Irvine, CA, USA.
Vivek SwarupCenter for Complex Biological Systems (CCBS), University of California, Irvine, Irvine, CA, USA.

Funding

Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTIAN, BRADLEY T, HANDEN, BENJAMIN L · 2020 to 2025
$103.7M
UC Irvine MODEL-ADU54AG054349 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Craig E Stark · 2017 to 2026
$71.9M
Project 3: Neuropathology of the multi-proteinopathy of c9FTD/ALS.P01NS084974 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2014 to 2024
$17.6M
Dynamic epigenomic landscape of opioid abuse following early-life adversityU01DA053826 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Tallie Z. Baram, CHRISTIE D FOWLER · 2022 to 2026
$3.4M
Mentor Training to enhance mentorship in an interdisciplinary training programT32GM136624 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Arthur D Lander, Qing Nie · 2020 to 2026
$3.1M
Oligodendrocyte heterogeneity in Alzheimer' s diseaseRF1AG071683 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SWARUP, VIVEK, ZHANG, JING · 2021 to 2024
$2.2M
Oligodendrocyte heterogeneity in Alzheimer' s diseaseR01AG071683 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SWARUP, VIVEK · 2024 to 2025
$1.2M
NIA NIH HHS R01 AG071683NIA NIH HHS RF1 AG071683NIA NIH HHS U19 AG068054NIA NIH HHS U54 AG054349NIDA NIH HHS U01 DA053826NIGMS NIH HHS T32 GM136624NINDS NIH HHS P01 NS084974
6 · The paper itself

Abstract

Biological systems are immensely complex, organized into a multi-scale hierarchy of functional units based on tightly regulated interactions between distinct molecules, cells, organs, and organisms. While experimental methods enable transcriptome-wide measurements across millions of cells, popular bioinformatic tools do not support systems-level analysis. Here we present hdWGCNA, a comprehensive framework for analyzing co-expression networks in high-dimensional transcriptomics data such as single-cell and spatial RNA sequencing (RNA-seq). hdWGCNA provides functions for network inference, gene module identification, gene enrichment analysis, statistical tests, and data visualization. Beyond conventional single-cell RNA-seq, hdWGCNA is capable of performing isoform-level network analysis using long-read single-cell data. We showcase hdWGCNA using data from autism spectrum disorder and Alzheimer's disease brain samples, identifying disease-relevant co-expression network modules. hdWGCNA is directly compatible with Seurat, a widely used R package for single-cell and spatial transcriptomics analysis, and we demonstrate the scalability of hdWGCNA by analyzing a dataset containing nearly 1 million cells.

Indexed as

Alzheimer DiseaseAutism Spectrum DisorderGene Expression ProfilingGene Regulatory NetworksHumansTranscriptomeAlzheimer's diseaseAutism spectrum disorderco-expression networkgene networklong-read RNA-seqmicrogliasingle-cell genomicssingle-cell RNA-seqspatial transcriptomics

Identifiers

PMID37426759
PMCPMC10326379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.